Advenica AB (ADVE)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 17.04 |
|---|---|
| 52-week range | 12.92 – 29.20 |
| Return, 1 month / 3 months | −1.2% / +0.8% |
| Return, 1 year / 3 years | +2.6% / +105.0% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 58.8% |
| Worst drawdown (1 year) | -38.3% |
| Average daily value traded | 0.62M SEK |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Advenica AB is a Swedish cybersecurity company that develops encryption and secure information-sharing products. Its offerings include network encryptors, secure data diodes and related systems that protect classified and sensitive information as it moves between networks. Customers are mainly government agencies, defence organisations and other bodies that need to safeguard communications and data. The company is based in Sweden and works with clients in markets where information security requirements are strict.
On this site Advenica AB appears as a stock on the Stockholm Exchange (Sweden), code ADVE, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Advenica AB (ADVE) trades on the Stockholm Exchange in Sweden. It last closed at SEK 17.04 on 19 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 550 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.6% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.7% | ||
| From 52-week high | -35.7% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | -20.4% | ||
| 12-month return, skipping the last month | 3.8% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.3% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.62M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 10 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.1% |
|---|---|
| 1 month | −1.2% |
| 3 months | +0.8% |
| 6 months | −20.4% |
| 1 year | +2.6% |
| 3 years | +105.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 17.33 / 18.27 |
|---|---|
| Golden / death cross (60 days) | Death, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Apr 2026 | SEK 0.1400 |
| 25 Apr 2025 | SEK 0.0900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.